Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

385 Results Found

FacilityOS: Healthcare Logistics Compliance Playbook

Discover where compliance risks arise, practical strategies to improve documentation and accessibility and how digital tools are simplifying audits.

Harnessing the Power of Partnerships

AHA Leadership Scan: A Series of Virtual Panel DiscussionsHarnessing the Power of Partnerships 

AHRMM Podcast

The AHRMM Power Up Podcast Series, a podcast dedicated to health care supply chain professionals. Hosted by Mike Schiller and Justin Poulin, this groundbreaking series explores the latest trends, strategic insights, and innovative solutions in the health care supply chain industry.
Public

AHA Statement to House Energy & Commerce Subcommittee on Health Hearing for June 11, 2025

AHA statement for the record to the Committee on Energy and Commerce Health Subcommittee hearing “Made in America: Strengthening Domestic Manufacturing and the Health Care Supply Chain.”

Executive Summary: Tariffs and Their Impact on the U.S. Health Care Supply Chain

The U.S. health care system relies heavily on a global supply chain for pharmaceuticals and medical devices.
Public

AHA Comments on the Proposed Change to Section 301 Tariffs for Goods Made in China – 90183100

June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508
Public

Costs of Caring

This report outlines the key trends impacting hospital financial stability in 2025.
Public

America Needs Strong Hospitals to Support Healthy and Thriving Communities

We are continuing our full court press to make the case to lawmakers that enacting significant cuts to Medicaid would jeopardize access to care for the more than 72 million people who rely on the program.

AHA urges USTR not to increase tariffs on health care products made in China 

The AHA sent a letter June 28 to the U.S. Trade Representative responding to a proposed increase in Section 301 tariffs for goods produced in China, which would include health care products.